Tech Company Financing Transactions
Respiro Diagnostics Funding Round
On 7/8/2026, Respiro Diagnostics secured $1.3 million in Seed financing from SFC Capital, Zinc and Amadeus Capital.
Transaction Overview
Company Name
Announced On
7/8/2026
Transaction Type
Venture Equity
Amount
$1,300,000
Round
Seed
Investors
Proceeds Purpose
The funding will support Respiro's clinical research and the continued development of its breath collection device and laboratory platform as the company advances towards clinical validation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
International House, 14 King Street
Leeds, LS1 2HL
UK
Leeds, LS1 2HL
UK
Phone
Undisclosed
Website
Email Address
Overview
We're developing a breakthrough platform that captures molecular signals from the lungs, without relying on imaging or invasive procedures. Our approach is built on a proprietary sample collection and analysis process, designed to deliver high-resolution molecular data to enable earlier, more accurate detection. Currently in development, our platform is engineered to overcome the limitations of today's screening tools, with the goal of making powerful respiratory diagnostics accessible and scalable in routine care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Theo Issitt
Founder
Alison Quinn
Browse more venture capital transactions:
Prev: 7/7/2026: Luffy AI venture capital transaction
Next: 7/8/2026: Aardaia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs